Donald Mazzulla, MD
Retina Specialist · New Orleans, LANPI 1740443522
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $177,902 of the $215,067 with a category attached, or 82.7%. 18 manufacturers reported payments, led by Alimera Sciences, Inc. at 35.4% of the total. Reporting peaked in 2024 at $53,579 and has fallen 56.4% since, to $23,376 in 2025. Among retina specialist clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 319 payments — averaging $674.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alimera Sciences, Inc.$76K
- AbbVie$69K
- Apellis Pharmaceuticals, Inc.$52K
- ANI Pharmaceuticals, Inc.$10K
- Regeneron Healthcare Solutions, Inc.$4K
- Alcon$928
- plus $3K from 12 others
Across 1 payment — averaging $5235.12 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$5K
What the payments were for
- Consulting fees$6,5633%
- Speaking & faculty fees$177,90283%
- Travel & lodging$19,6199%
- Food & beverage$10,9835%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alimera Sciences, Inc. | 110 | $76,032 |
| AbbVie(2 entities) | 76 | $69,261 |
| Apellis Pharmaceuticals, Inc. | 39 | $51,968 |
| ANI Pharmaceuticals, Inc. | 27 | $9,979 |
| Regeneron Healthcare Solutions, Inc. | 25 | $3,855 |
| Alcon | 6 | $928 |
| Regeneron | 5 | $638 |
| Coherus Oncology, Inc. | 7 | $530 |
| Mallinckrodt Hospital Products Inc. | 4 | $491 |
| Astellas Pharma US Inc | 9 | $381 |
| Genentech USA, Inc. | 2 | $152 |
| Glaukos Corporation | 1 | $149 |
| Genentech, Inc. | 1 | $147 |
| Tarsus Pharmaceuticals, Inc. | 1 | $122 |
| Dompe US, Inc. | 1 | $120 |
| Spark Therapeutics, Inc. | 1 | $115 |
| Sun Pharmaceutical Industries Inc. | 1 | $111 |
| Novartis | 3 | $90 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$215,067 in reported general payments places this provider in the 95th percentile of 30 retina specialist providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 73 | $5,199 |
| Atropine Sulfate | 28 | $1,804 |
| Brimonidine Tartrate | 56 | $1,323 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 85 | $1,205 |
| Ketorolac Tromethamine | 22 | $706 |
| Dorzolamide Hcl | 20 | $529 |
| Acetazolamide ErAcetazolamide | 13 | $452 |
| Latanoprost | 26 | $249 |
| Timolol Maleate | 26 | $183 |
| Ondansetron Hcl | 69 | $177 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 63 | $134 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in New Orleans
- Sidharth PuriNew Orleans$32K
- Joseph BeneventoNew Orleans$4K
- Gwen CousinsMetairie$10K
- Frank CulottaLafayette$9K
- Adam JanotBaton Rouge$8K
- Daniel SalisburyBaton Rouge$7K
- Scott GauthreauxLafayette$7K
- Brett BuddenMetairie$6K
- Arley Jaramillo RodriguezMetairie$6K
- Neil NotarobertoMetairie$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.